GPX4 and metabolic dysfunction-associated steatohepatitis: Further mechanistic studies have found that GPX4 can slow down NASH progression via inhibiting ferroptosis, and RSL-3, an inhibitor of GPX4, aggravated the liver image of NASH by facilitating ferroptosis in MCD diet-fed mice.